Functional Skills

Accounts Receivable
Accounts Payable
Accounting
Budgeting
Purchasing
HR System Implementation
Operations Management
Communications
Forecasting / Projections
Finance Transformation
Accounting Software Implementation
Sales and Operations Planning (S&OP)
Financial Planning & Analysis (FP&A)
Cost Reduction
ERP Management & Configuration

Software Skills

ADP
Dynamics 365
Quickbooks
Quickbooks Enterprise
Sage Business Cloud X3

Sector Experience

Business Services
Financial Services
Life Sciences & Pharma
Technology
Telecom
Fortune 500

Experience

PreludeTherapeutics Accounting
Vice President, Head of Finance & Controller
3/2020 - 11/2024
Clinical stage precision oncology company (NASDAQ: PRLD) focused on discovering and developing small molecule therapies. Vice President, Head of Finance & Controller responsible for all accounting and financial functions including financial close process, operational accounting, equity administration, audit and tax compliance, treasury management, SOX 404a compliance and SEC reporting. Built accounting and finance function to support IPO and growth of company from 40 to 135 employees.
• Implemented accounting and financial systems to support IPO and scalability of the company to support the day-to-day operations of the procure-to-pay cycles, including accounts payable, purchasing, and financial reporting systems. Conversion of accounting system from QuickBooks to Microsoft Dynamics 365.
• Built accounting team of seven to support company growth and strengthen internal controls to be GAAP and SOX 404a compliant in a 100% virtual environment.

TELA Bio, Inc Accounting
Senior Director Accounting Operations
7/2012 - 2/2020
Medical device company (NASDAQ: TELA)focused on biosynthetic surgical reconstruction products used in general surgery. Senior Director Accounting Operations responsible for all accounting and financial functions of a global organization including revenue, operational accounting, budgeting, and reporting, financial analysis, coordination of external audits and treasury management. Built accounting and finance function from inception through IPO and commercialization.
• Implemented Sage X3 ERP to ensure smooth functioning in the day-to-day operations of the order-to-cash and procure-to-pay cycles, including accounts payable, accounts receivable, credit, collections, and sales commissions.
• Improved timeliness and quality of management reporting through implementation of Prophix software improving departmental reporting and communications of results to TLT monthly.
• Implemented Concur Travel and Expense solution

PhaseBio Pharmaceuticals Accounting
Controller Consultant
1/2010 - 6/2015
Controller for a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases (NASDAQ: PHAS). Controller responsible for all accounting and financial reporting for private, pre-revenue company.
•Provided Controller level expertise including maintaining the daily operations, coordinating annual federal/state tax filings and annual audits with external accountants.
•Analyzed and implemented programs for G&A cost savings as well as procedures to ensure proper controls.
•Implemented Morgan Stanley Shareworks for stock option tracking and expense calculation.

AZELON PHARMACEUTICALS, INC. (f/k/a Zelos Therapeutics, Inc) Accounting
Controller
1/2009 - 6/2015
Clinical-stage biotechnology company focused on the development of innovative treatments for bone disorders and related indications. Controller responsible all accounting and financial reporting functions including accounts payable, payroll, external reporting, budget and treasury management for US and Canadian operations.
• Coordinated annual tax filings for US, Canada and Nova Scotia companies recovering over $200k in back taxes.
• Spearheaded annual renewals of insurance and benefit programs reducing overall costs by 40%.
• Resolution of vendor and investor requests including renegotiation of note with Canadian government.

Nucleonics Inc. Accounting
Controller
1/2003 - 12/2008
Privately held venture-backed clinical-stage biotechnology company focused on the development of novel RNAi therapeutics for infectiousdiseases, cancer and inflammatory conditions based on proprietary gene silencing technology.
Controller responsible for all accounting and financial reporting functions including accounts payable, payroll, and treasurymanagement.
• Tracked NIH grant expenditures and filed federal reports to ensure compliance with government regulations.
• Implemented and administered MAS90 accounting system, FRX reporting and FAS (Fixed Asset System) tracking over $2 million in company assets after system conversion from QuickBooks.
• Developed Pennsylvania Research and Development program netting over $400k annually in funding proceeds.

HR Logic, Inc. Accounting
Accounting Consultant
9/2000 - 8/2004
Privately held PEO providing payroll and benefits outsourcing solutions to companies nationwide.
Accounting Consultant for a $1.9 billion operation with over five hundred employees nationwide.
• Streamlined cash management function reducing $500k in annual bank fees via consolidation of nationwide banking structures and implementation of lock boxes.
• Participated in integration of new payroll system and accounts receivable conversion to PeopleSoft resolving conversion issues with payroll vendors in a timely manner.
• Prepared monthly cash and tax analysis and amendments of state, federal and local returns to ensure compliance with federal and state regulations. Negotiated monetary settlement of tax issues with agencies.

Comcast Accounting
Commission Manager
1/1997 - 12/1999
Wireless cellular phone carrierforthe tri-state area sold to SBC Communicationsin 1999. Commissions Manager, responsible forthe calculation and reporting ofthree hundred sales employees and six hundred agent commissions with fifteen member staff, who calculated $50 million in annual commissions payable.
• Streamlined commissions processing and implemented checks and balances to efficiently calculate monthly commissions and management reporting, reducing errors to less than 2%.
• Implemented detailed and timely reporting of monthly commission expenditures by market and established accounts receivables/credit limits by agent.
• Spearheaded development and implementation of customized system which automated manual processing of commission payments. Fraudulent detection oftransactions reduced staffing level by 50%.